The direction of the risk for Alzheimer’s disease and related dementias differed based on the quality of a plant-based diet, according to data published in Neurology.
See the article HERE
A diet that’s rich in plant-based foods can be healthier for you and your brain — even if you start it later in life, a new study found.
Eating high-quality plant foods like vegetables, whole grains, fruits, nuts and legumes was associated with a reduced risk for Alzheimer’s and dementia in the study, published April 8 in Neurology, the journal for the American Academy of Neurology.
Read more HERE
Increasing the number of steps you take every day may slow cognitive decline in older adults who already have biological signs of early Alzheimer’s disease, according to a new observational study.
The presence of beta amyloid and tau proteins are hallmark signs of Alzheimer’s. Amyloid can begin to accumulate in the spaces between neurons as early as one’s 30s, potentially affecting communication between brain cells. As amyloid deposits grow, they can lead to a rapid spread of abnormal tau proteins, which form tangles inside brain cells, thus killing them.
Read more HERE
Researchers across USC are studying how lifestyle and environment influence dementia risk and resilience. They’re finding that what’s good for the body is also good for the brain.
Read more about it HERE
Older people with a genetic risk of Alzheimer’s disease did not experience the expected increase in cognitive decline and dementia risk if they consumed relatively large amounts of meat. This is shown in a new study from Karolinska Institutet published in JAMA Network Open. The results may contribute to the development of more individually tailored dietary advice.
Read more about it HERE
An earlier diagnosis and intervention strategy for Alzheimer’s disease is on the horizon, signaling a need to overhaul current detection methods and patient care protocols, experts at the Alzheimer’s Association Research Roundtable (AARR) said.
“Advances in biomarker technology, digital cognitive assessments, and amyloid-targeting therapies have redefined the opportunities for accurate and early diagnosis and care of Alzheimer’s disease,” reported Christopher Weber, PhD, of the Alzheimer’s Association in Chicago, and co-authors in Alzheimer’s & Dementia: Translational Research & Clinical Interventions.
These advances create new possibilities to intervene before the onset of cognitive impairment, Weber and colleagues wrote. Targeting the earliest stages of Alzheimer’s, Weber said, “is similar to how doctors treat other diseases like heart disease and some cancers, where early detection and prevention are key parts of care.”
Read more HERE